The clonal evolution of two distinct T315I-positive BCR-ABL1 subclones in a Philadelphia-positive acute lymphoblastic leukemia failing multiple lines of therapy: a case report

BACKGROUND: The treatment of Philadelphia chromosome-positive Acute Lymphoblastic Leukemia (Ph+ ALL) patients who harbor the T315I BCR-ABL1 mutation or who have two or more mutations in the same BCR-ABL1 molecule is particularly challenging since first and second-generation Tyrosine Kinase Inhibitor...

Descripción completa

Detalles Bibliográficos
Autores principales: De Benedittis, Caterina, Papayannidis, Cristina, Venturi, Claudia, Abbenante, Maria Chiara, Paolini, Stefania, Parisi, Sarah, Sartor, Chiara, Cavo, Michele, Martinelli, Giovanni, Soverini, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545087/
https://www.ncbi.nlm.nih.gov/pubmed/28779753
http://dx.doi.org/10.1186/s12885-017-3511-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5545087/
https://www.ncbi.nlm.nih.gov/pubmed/28779753
http://dx.doi.org/10.1186/s12885-017-3511-2

Ejemplares similares